Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph M Herman

Showing results (281-290 of 316) with videos related to

Pageof 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancerChristine A Iacobuzio-Donahue, Baojin Fu, Shinichi Yachida, et al.
Advances in Radiation Oncology|December 22, 2021
Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern EraJoseph Abi Jaoude, Connor P Thunshelle, Ramez Kouzy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins HospitalJoseph M Herman, Michael J Swartz, Charles C Hsu, et al.
International Journal of Radiation Oncology, Biology, Physics|September 26, 2017
A Novel Absorbable Radiopaque Hydrogel Spacer to Separate the Head of the Pancreas and Duodenum in Radiation Therapy for Pancreatic CancerAvani D Rao, Ziwei Feng, Eun Ji Shin, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2016
Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic CancerAaron T Wild, Joseph M Herman, Avani S Dholakia, et al.
Plos One|June 14, 2013
Concurrent versus sequential sorafenib therapy in combination with radiation for hepatocellular carcinomaAaron T Wild, Nishant Gandhi, Sivarajan T Chettiar, et al.
JAMA Surgery|June 9, 2016
Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101Matthew H G Katz, Qian Shi, Syed A Ahmad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2013
Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final resultsJoseph M Herman, Aaron T Wild, Hao Wang, et al.
Learning Health Systems|January 17, 2025
The power of personas: Exploring an innovative model for understanding stakeholder perspectives in an oncology learning health networkDylan J Cooper, Jessie Karten, Sarah E Hoffe, et al.
Advances in Radiation Oncology|April 29, 2021
Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic CancerShalini Moningi, Joseph Abi Jaoude, Ramez Kouzy, et al.
Pageof 32

Showing results (281-290 of 316) with videos related to

Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancerChristine A Iacobuzio-Donahue, Baojin Fu, Shinichi Yachida, et al.
Advances in Radiation Oncology|December 22, 2021
Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern EraJoseph Abi Jaoude, Connor P Thunshelle, Ramez Kouzy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins HospitalJoseph M Herman, Michael J Swartz, Charles C Hsu, et al.
International Journal of Radiation Oncology, Biology, Physics|September 26, 2017
A Novel Absorbable Radiopaque Hydrogel Spacer to Separate the Head of the Pancreas and Duodenum in Radiation Therapy for Pancreatic CancerAvani D Rao, Ziwei Feng, Eun Ji Shin, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2016
Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic CancerAaron T Wild, Joseph M Herman, Avani S Dholakia, et al.
Plos One|June 14, 2013
Concurrent versus sequential sorafenib therapy in combination with radiation for hepatocellular carcinomaAaron T Wild, Nishant Gandhi, Sivarajan T Chettiar, et al.
JAMA Surgery|June 9, 2016
Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101Matthew H G Katz, Qian Shi, Syed A Ahmad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2013
Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final resultsJoseph M Herman, Aaron T Wild, Hao Wang, et al.
Learning Health Systems|January 17, 2025
The power of personas: Exploring an innovative model for understanding stakeholder perspectives in an oncology learning health networkDylan J Cooper, Jessie Karten, Sarah E Hoffe, et al.
Advances in Radiation Oncology|April 29, 2021
Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic CancerShalini Moningi, Joseph Abi Jaoude, Ramez Kouzy, et al.
Pageof 32